Domestic:
+91 92 5656 7676
International:
+1 647 893 7323


ETHNEM™ - 1.5GM
Meropenem Sulbactam for Injection
PACKING SIZE / TYPE
20ML WITH CARTON
Summary
ETHNEM™ - 1.5GM Injection: is a broad-spectrum antibiotic containing Meropenem and Sulbactam, used for treating severe bacterial infections. Meropenem, a carbapenem antibiotic, works by inhibiting bacterial cell wall synthesis, while Sulbactam enhances its efficacy by inhibiting beta-lactamase enzymes that bacteria use to resist antibiotics. This combination is particularly effective against multi-drug-resistant (MDR) bacteria and is commonly used in hospitals for life-threatening infections.
Side Effects
While generally well-tolerated, ETHNEM™ - 1.5GM Injection may cause some side effects, including:
Common Side Effects
Nausea, vomiting
Diarrhea
Headache
Rash
Injection site reactions (pain, redness, swelling)
Serious Side Effects (Rare but Critical)
Seizures (more common in patients with renal impairment)
Severe allergic reactions (anaphylaxis, angioedema)
Clostridium difficile-associated diarrhea
Liver enzyme elevation (Hepatitis, Jaundice)
Blood disorders (Neutropenia, Thrombocytopenia)
If severe side effects occur, medical attention is required immediately.
Usage
Administered intravenously (IV) in hospitals under medical supervision.
Dosage depends on the severity of the infection, kidney function, and patient weight.
Typically given every 8 hours as an IV infusion over 15-30 minutes.
Must be prepared and administered by a healthcare professional.
Concerns
Key Considerations
Renal Impairment: Dosage adjustment required.
Neurotoxicity: Can cause seizures in patients with brain disorders.
Antibiotic Resistance: Use only for confirmed bacterial infections to prevent resistance development.
Clostridium difficile Risk: Can disrupt gut microbiota, leading to severe diarrhea.
Superinfection Risk: Prolonged use may cause fungal or secondary bacterial infections.
When not to use?
ETHNEM™ - 1.5GM Injection is contraindicated in:
Patients with a known allergy to Meropenem, Sulbactam, or other beta-lactam antibiotics (Penicillins, Cephalosporins, Carbapenems).
Individuals with a history of severe hypersensitivity reactions (Anaphylaxis, Steven-Johnson Syndrome).
Severe renal failure without proper dose adjustment.
Neonates and infants without medical consultation.
Warnings
ETHNEM™ - 1.5GM Injection is contraindicated in:
Patients with a known allergy to Meropenem, Sulbactam, or other beta-lactam antibiotics (Penicillins, Cephalosporins, Carbapenems).
Individuals with a history of severe hypersensitivity reactions (Anaphylaxis, Steven-Johnson Syndrome).
Severe renal failure without proper dose adjustment.
Neonates and infants without medical consultation.
Dosage
Standard Adult Dose
Mild to moderate infections: 1.5g IV every 8 hours
Severe infections (e.g., Meningitis, Pneumonia, Septicemia): 1.5-3g IV every 8 hours
Renal Impairment: Dose adjustment based on creatinine clearance (CrCl)
Children: Dose based on weight (as per doctor’s prescription)
Interactions
ETHNEM™ - 1.5GM Injection may interact with:
Valproic Acid & Divalproex: Can reduce valproic acid levels, increasing seizure risk.
Probenecid: Delays Meropenem elimination, increasing toxicity risk.
Other Beta-Lactam Antibiotics: Avoid combining with other carbapenems to prevent toxicity.
Aminoglycosides (Gentamicin, Amikacin): Increased risk of nephrotoxicity.
Blood Thinners (Warfarin): Can enhance anticoagulant effects, increasing bleeding risk.
General Instructions
ETHNEM™ - 1.5GM Injection
Do not self-administer; must be given by a healthcare professional.
Complete the full course even if symptoms improve.
Stay hydrated to minimize kidney-related side effects.
Report any allergic reactions (rash, swelling, breathing issues) immediately.
Inform the doctor of any ongoing medications, kidney disease, liver disease, or neurological conditions.
Other Details
Storage: Keep in a cool, dry place below 25°C. Protect from light and moisture.
Reconstitution: Use sterile water or compatible IV fluids; use immediately after mixing.
Prescription Required: Strictly administered under medical supervision.
References
Clinical Infectious Diseases Journal – Guidelines on Carbapenem Use.
World Health Organization (WHO) – Meropenem Drug Information.
National Institutes of Health (NIH) – Drug Interaction and Safety Data.
Indian Pharmacopoeia & FDA Guidelines – Approved Uses and Dosage.
